Program details
Please join Blood Cancer United for this FREE informative and empowering educational program designed for individuals affected by blood cancers. This session will highlight key updates from the annual meeting of the American Society of Hematology (ASH), with a focus on the latest developments in lymphoma and chronic myeloid leukemia (CML). Our expert speakers will translate the latest research advances into clear, practical insights that people affected by any type of blood cancer can understand and apply.
Our expert speakers will review important breakthroughs in treatments, emerging therapies, clinical trials, and evolving standards of care across blood cancer. Most importantly, we will focus on what these updates mean for patients and survivors today, including treatment decisions, side effect management, quality of life, and long-term outcomes. Attendees will gain tools to advocate for themselves, ask informed questions, and partner confidently with their healthcare team.
Whether you are newly diagnosed, in active treatment, or well into survivorship, this program aims to provide knowledge, reassurance, and practical strategies to help you move forward with clarity and confidence.
We encourage you to invite your caregiver and family members.
National support for this program provided by:
Genentech, A Member of the Roche Group
Novartis
In local collaboration with:
Cure Today
Roswell Park Comprehensive Cancer Center